Skip to main content
Journal cover image

Redefining Early Neurological Improvement After Reperfusion Therapy in Stroke.

Publication ,  Journal Article
Agarwal, S; Cutting, S; Grory, BM; Burton, T; Jayaraman, M; McTaggart, R; Reznik, M; Scher, E; Chang, AD; Frontera, J; Lord, A; Rostanski, S ...
Published in: J Stroke Cerebrovasc Dis
February 2020

BACKGROUND AND PURPOSE: Early neurologic improvement (ENI) in patients treated with alteplase has been shown to correlate with functional outcome. However, the definition of ENI remains controversial and has varied across studies. We hypothesized that ENI defined as a percentage change in the National Institute of Health Stroke Scale (NIHSS) score (percent change NIHSS score) at 24-hours would better correlate with favorable outcomes at 3 months than ENI defined as the change in NIHSS score (delta NIHSS score) at 24 hours. METHODS: Retrospective analysis of prospectively collected single-center quality improvement data was performed of all acute ischemic stroke (AIS) patients treated with alteplase. We examined delta NIHSS score and percent change NIHSS score in unadjusted and adjusted logistic regression models as predictors of a favorable outcome at 3 months (defined as mRS 0-1). RESULTS: Among 586 patients who met the inclusion criteria, 194 (33.1%) had a favorable outcome at 3 months. In fully adjusted models, both delta NIHSS score (OR per point decrease 1.27; 95% confidence interval [CI] 1.19-1.36) and percent change NIHSS score (OR per 10 percent decrease 1.17; 95% CI 1.12-1.22) were associated with favorable functional outcome at 3 months. Receiver operating characteristic (ROC) curve comparison showed that the area under the ROC curve for percent change NIHSS score (.755) was greater than delta NIHSS score (.613) or admission NIHSS (.694). CONCLUSIONS: Percentage change in NIHSS score may be a better surrogate marker of ENI and functional outcome in AIS patients after receiving acute thrombolytic therapy. More studies are needed to confirm our findings.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Stroke Cerebrovasc Dis

DOI

EISSN

1532-8511

Publication Date

February 2020

Volume

29

Issue

2

Start / End Page

104526

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Time Factors
  • Thrombolytic Therapy
  • Stroke
  • Retrospective Studies
  • Reproducibility of Results
  • Recovery of Function
  • Predictive Value of Tests
  • Neurology & Neurosurgery
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Agarwal, S., Cutting, S., Grory, B. M., Burton, T., Jayaraman, M., McTaggart, R., … Yaghi, S. (2020). Redefining Early Neurological Improvement After Reperfusion Therapy in Stroke. J Stroke Cerebrovasc Dis, 29(2), 104526. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104526
Agarwal, Shashank, Shawna Cutting, Brian Mac Grory, Tina Burton, Mahesh Jayaraman, Ryan McTaggart, Michael Reznik, et al. “Redefining Early Neurological Improvement After Reperfusion Therapy in Stroke.J Stroke Cerebrovasc Dis 29, no. 2 (February 2020): 104526. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104526.
Agarwal S, Cutting S, Grory BM, Burton T, Jayaraman M, McTaggart R, et al. Redefining Early Neurological Improvement After Reperfusion Therapy in Stroke. J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104526.
Agarwal, Shashank, et al. “Redefining Early Neurological Improvement After Reperfusion Therapy in Stroke.J Stroke Cerebrovasc Dis, vol. 29, no. 2, Feb. 2020, p. 104526. Pubmed, doi:10.1016/j.jstrokecerebrovasdis.2019.104526.
Agarwal S, Cutting S, Grory BM, Burton T, Jayaraman M, McTaggart R, Reznik M, Scher E, Chang AD, Frontera J, Lord A, Rostanski S, Ishida K, Torres J, Furie K, Yaghi S. Redefining Early Neurological Improvement After Reperfusion Therapy in Stroke. J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104526.
Journal cover image

Published In

J Stroke Cerebrovasc Dis

DOI

EISSN

1532-8511

Publication Date

February 2020

Volume

29

Issue

2

Start / End Page

104526

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Time Factors
  • Thrombolytic Therapy
  • Stroke
  • Retrospective Studies
  • Reproducibility of Results
  • Recovery of Function
  • Predictive Value of Tests
  • Neurology & Neurosurgery